Check these numbers before you buy any stock
David Cohne offers a crash course in fundamental analysis… and explains which numbers to focus on when looking at financial statements.
3 defensive stocks for a volatile market
Volatility surged this week as investors focused on the latest inflation numbers. David Cohne explains why safer, defensive stocks are great in any market conditions… and reveals his 3 favorite names to buy today.
Get ready… the Fed won’t fight inflation this time
Genia explains why the Fed has no choice but to let inflation loose... why you should prepare for even higher inflation ahead… and what investors should do in this environment.
3 rules for knowing when to sell a stock
Fear can overwhelm our logic… especially when deciding whether to sell a stock at a loss. Having a set of rules can help keep you from making fear-based decisions.
Don’t miss this 2-week window
Luke digs into the benefits of investment retirement accounts (IRAs)... and shows how contributing to one every year can generate a fortune over time.
The bitcoin legitimacy debate has been settled
Daniel Creech highlights JPMorgan’s latest plans to launch its own bitcoin fund… and explains the biggest future threat for crypto investors.
What to buy if you’re worried about rising taxes
Luke Downey explains why you should ignore worries about a capital gains tax hike... and invest in a sector that stands to benefit instead.
Tesla vs. NIO: Which is a better play on the electric vehicle boom?
In part 2 of his series on growth metrics, David Cohne puts Tesla up against NIO to see which stock is the better way to play the booming EV market... The winner may surprise you.
Become a millionaire the easy way
In three charts, Genia illustrates why nothing works as consistently as reinvesting dividends to help you build wealth over time. It’s a strategy many of us wish we’d understood at 20… so please share this article with young friends and…
Watch this sector for upside this earnings season
Luke Downey explains why you should always focus on a company’s guidance during earnings season… and gives his favorite sector to watch for huge upside potential.
My 3 favorite metrics to determine growth potential
David Cohne explains how to analyze a company’s growth profile using three important measures.
Why Pfizer is a better buy than Johnson & Johnson
In part three of David Cohne’s valuation series, he walks us through a comparison of two popular pharma stocks using five valuation metrics. Whenever you're deciding between two stocks to buy, keep this guide handy...
A strategy to make money in any market (and impress your friends)
Genia explains how pairs trading works… and when to use it to your advantage.
Search by
